How Much Is Mounjaro Now — UK Pricing, What's Included and What to Watch For

The price you see quoted is rarely the price you end up paying

Picture this: you search Mounjaro pricing, find a figure that looks manageable and click through to order, only to discover a consultation fee sitting separately on the checkout page, a prescription charge on top, and a delivery option that costs extra unless you opt in to a plan. That gap between the headline number and the total cost is the most common frustration people bring to our frequently asked questions.

Private Mounjaro pricing in the UK is set at provider level, not by Eli Lilly directly. The manufacturer's list price is what Lilly charges the pharmacy; what a patient pays also reflects the cost of the clinical infrastructure around the medicine. Legitimate private providers cover a consultation, a qualified prescriber reviewing your answers, a prescription, dispensing, and delivery. When those elements are bundled into one figure it looks higher than a bare-medicine price, but the total outlay is often similar, or the unbundled option turns out more expensive once everything is added.

The dose also matters enormously. Starting doses (2.5mg) carry a lower price per pen than the higher therapeutic doses; as your prescriber titrates upward, the per-month cost rises too. Pages covering what 5mg costs specifically or 10mg pricing in context walk through how those figures compare. The practical checking habit worth building now: pull up the GPhC pharmacy register in a new tab alongside any quote you are comparing, it takes under a minute to verify the registration number and confirm you are looking at a regulated pharmacy, not an unlicensed seller.

Why Mounjaro prices shifted sharply in autumn 2025

The Lilly list-price revision in September 2025 was the single biggest factor reshaping what patients see quoted across the private market. Before that date the highest-dose (15mg) pen carried a list price of around £122; after it, that figure rose to around £330, a change that fed through to private providers at different speeds and to different degrees. Widely reported at the time, the revision reflected the medicine moving out of an introductory pricing period.

For patients already on treatment, the shift meant mid-course costs changed without any change to their clinical programme. For people researching the medicine now, it means any price comparison article or forum post from before September 2025 is likely to quote figures that no longer apply. If you want to check what the Mounjaro price looks like right now, that page covers the current position in detail, and the current Mounjaro pricing picture and how it breaks down by dose is covered in more detail for anyone mapping out a budget.

NICE's appraisal of tirzepatide (Technology Appraisal TA1026, published December 2024) also reshaped the conversation about value, because it confirmed the clinical evidence base that supports the higher price point. That appraisal is worth reading if you want to understand what the trial data actually showed.

What a single, all-in price is designed to do

At nume, one price covers everything on the list above: consultation, prescription, the medicine itself, next-working-day DPD delivery to your door in plain packaging, and aftercare seven days a week. There is no subscription, no auto-renewal and no separate fee waiting at any stage. Every repeat order is reviewed by a prescriber before it goes out. We are deliberately not the cheapest option in the market, that is a choice, not an oversight. The money that would go on discounts goes on the clinical infrastructure: our prescribers, identity and weight verification at every step, and same-day review of your consultation by a real clinician, not an automated system.

What's included in a provider's price is worth checking in the same breath as the number itself. A lower headline that adds prescription fees, delivery charges and a consultation cost can land higher than a bundled alternative, and our page on Mounjaro prices now gives you an up-to-date reference point for doing that comparison with confidence. The side-by-side breakdown of what different pricing structures include is a useful reference for anyone doing that arithmetic. For a broader look at the treatment itself before thinking about cost, the Mounjaro overview covers the clinical picture.

The cheapest listing answers the wrong question when the medicine is a POM

Mounjaro is a Prescription-Only Medicine. The MHRA has been clear (and has seized approximately 20 million doses worth around £45 million from illicit UK supply chains) that fake and unlicensed tirzepatide pens are circulating, including some manufactured at an illegal UK site raided in Northampton in October 2025. Counterfeit pens have contained insulin. The lowest price in a search results page may be the one that bypasses clinical assessment entirely and ships from an unverified source. That is not a saving; it is a different kind of risk.

The markers of a legitimate route are straightforward: the pharmacy appears on the GPhC register, a qualified prescriber conducts a real clinical assessment, and you receive a proper prescription. Any seller offering tirzepatide without that assessment or quoting prices dramatically below the post-September 2025 market range warrants scrutiny, and suspected sellers can be reported via the MHRA's Yellow Card scheme. The right question, when weighing the cost of a prescription medicine, is not which number is smallest, it is which provider will look after you safely for as long as you need treatment.

If you are ready to start, or simply want to understand whether you are clinically suitable before committing to anything, start your free consultation with our prescribers. No fee to find out where you stand.